Ruling could spur tougher drug warnings

Bay State pharmaceutical companies could decide to strengthen safety warnings on their products after Wednesday's Supreme Court ruling made it easier for patients to sue drug makers for injuries. But overall, the ruling drew surprisingly little reaction from biotechnology companies and industry groups. (Full article: 468 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

• $4.95 1 article
• $9.95 4 articles
• $25.95 Monthly